「nest」の検索結果

Provides Better Auth integration patterns for NestJS backend and Next.js frontend with Drizzle ORM and PostgreSQL. Use when setting up Better Auth with NestJS backend, integrating Next.js App Router frontend, configuring Drizzle ORM schema, implementing social login (GitHub, Google), adding plugins (2FA, Organization, SSO, Magic Link, Passkey), implementing email/password authentication with session management, or creating protected routes and middleware.

日本語の概要は準備中です。原文の説明を表示しています。

Think and work like an expert Computational Neuroscientist. Use when a task calls for Computational Neuroscientist judgment. Reasons from encoding/decoding, GLM/LNP spike-train likelihood, mean-field E-I balance, and neural manifolds through NEST/Brian/NEURON/BMTK, GPFA/LFADS, Brain-Score alignment, and trained-RNN reverse engineering while treating spike-sorting contamination, model non-identifiability, nested-CV leakage, and task-optimization≠mechanism as first-class failure modes.

日本語の概要は準備中です。原文の説明を表示しています。

Your team has high autonomy — and standups are vague, weekly meetings drift into status reports, and 1:1s produce nothing but "I'm fine." This playbook fixes all three layers at once. What's inside: • Daily Standup system — 3-field format, good sample, 4 COO principles to keep it honest • Weekly Meeting — strict 25-min agenda, Scrum Master rotation, 0–10 pulse check • 1:1 Framework — 9-dimension quantified pulse, 5-group deep question bank, bilateral feedback structure • Diagnostic layer — "stuck-at" detection: info / authority / collaboration / capability / direction • FAQ for 4 common failure modes (dead standups, status-report meetings, "I'm fine" 1:1s, scaling beyond 10 people) 🇨🇳 你的团队自由度很高——但 standup 越来越糊，例会变成汇报，1:1 问不出真话。这套三层 Motivation 操作手册解决的正是这件事：standup 是信息层，例会是对齐层，1:1 是个人层。三件事做好了，motivation 不是管出来的，是长出来的。 🇯🇵 チームの自律性は高いのに、スタンドアップは曖昧で、週次ミーティングは進捗報告になり、1on1では「大丈夫です」しか返ってこない——このプレイブックは、その3層すべてを同時に解決します。 🇰🇷 팀의 자율성은 높은데 스탠드업은 두루뭉술하고, 주간 회의는 진척 보고가 되어버리고, 1:1에서는 진심을 들을 수 없다면 — 이 플레이북이 세 레이어 모두를 동시에 해결합니다. Triggers: "团队 motivation" | "standup 没人写" | "例会变成汇报" | "1:1 问不出真话" | "高自由度团队管理" | "COO 如何管人" | "team motivation" | "standup best practices" | "1on1 framework" | "weekly meeting template" | "チームモチベーション" | "팀 동기부여" | "AI startup team ops" | "remote team alignment" | "engagement下降"

Create or update root and nested AGENTS.md files that document scoped conventions, monorepo module maps, cross-domain workflows, and (optionally) per-module feature maps (feature -> paths, entrypoints, tests, docs). Use when the user asks for AGENTS.md, nested agent instructions, or a module/feature map.

日本語の概要は準備中です。原文の説明を表示しています。

Epistemic transparency — acknowledging uncertainty, flagging limitations, avoiding overconfidence, and communicating what is known, unknown, and uncertain with proportional confidence. Maps the HEXACO personality dimension to AI reasoning: truthful calibration of confidence, proactive disclosure of gaps, and resistance to the temptation to appear more certain than warranted. Use before presenting a conclusion, when answering questions where knowledge is partial or inferred, after noticing a temptation to state uncertain information as certain, or when a user is making decisions based on provided information.

日本語の概要は準備中です。原文の説明を表示しています。

Node.js backend conventions: project layout, configuration, logging, routing, and error handling patterns. Apply when implementing or modifying Node.js backend code in projects matching the nodejs stack profile. Use this skill to: - Pick conventional file/folder structure for a new module. - Wire configuration through env vars correctly. - Use the project's existing logger style. - Implement error handling that matches the framework (Express/Fastify/Koa). - Follow async/await patterns consistently. Do NOT use this skill for: - Frontend code (React/Vue/RN have their own conventions). - NestJS-specific patterns (decorators, DI, modules) — nest-plugin owns those. - Database schema design (call out as a sub-task; npm-patterns covers package management, not DB).

日本語の概要は準備中です。原文の説明を表示しています。

Initialize or migrate to nested CLAUDE.md structure for progressive disclosure. Claude auto-loads CLAUDE.md from any directory it enters, so nested files get discovered automatically. Use when setting up a new project's agent config, refactoring a bloated CLAUDE.md, or adding progressive disclosure to an existing repo. Triggers on: '/agent-init-deep', 'setup progressive disclosure', 'refactor claude.md', 'split claude.md', 'claude.md is too big'.

日本語の概要は準備中です。原文の説明を表示しています。

NestJS backend framework - modules, controllers, services, DI, guards, pipes, interceptors, exception filters, middleware, DTOs with class-validator

日本語の概要は準備中です。原文の説明を表示しています。

Structures biological experiments so inference is valid by construction, covering Fisher's principles (randomization, replication, local control), the experimental-vs-observational unit distinction and pseudoreplication (Hurlbert 1984; Lazic 2018), randomization mechanics (complete, restricted, stratified, rerandomization, run-order), blocking layouts (randomized complete block, Latin square, incomplete block), factorial designs and interactions, and the split-plot/nested error strata hidden inside multi-batch genomics. Use when deciding the experimental unit and what counts as a replicate, planning randomization and run order, choosing a blocked/factorial/split-plot/nested layout, avoiding pseudoreplication in cell-culture or animal studies, or specifying the random-effects structure of the analysis model. For assigning samples to sequencing batches/lanes/plates and batch-effect correction see experimental-design/batch-design; for regulated clinical-trial randomization see clinical-biostatistics.

日本語の概要は準備中です。原文の説明を表示しています。

Quantifies biodiversity from species abundance/incidence tables using Hill numbers (iNEXT) with coverage-based rarefaction-extrapolation (Chao & Jost 2012), asymptotic richness via Chao1/ACE/jackknife as a lower bound, Baselga turnover/nestedness partition with the Podani alternative as sensitivity check, mandatory Hellinger transformation before ordination (Legendre & Gallagher 2001), Faith PD and SES_MPD/SES_MNTD with explicit null-model choice, and Maire 2015 functional-diversity dimensionality optimization. Use when comparing diversity across sites with unequal sampling effort, picking the right richness estimator for singleton-heavy amplicon data, partitioning beta diversity into turnover vs nestedness, reporting Hill-number effective species counts rather than raw entropies, computing SES_MPD with explicit null-model justification, or deciding whether to apply standard metrics to compositional amplicon data. Not for clinical 16S microbiome diversity (see microbiome/diversity-analysis).

日本語の概要は準備中です。原文の説明を表示しています。

Produces a deep, honest peer-review of how someone uses Claude Code by statistically analyzing their local session data (~/.claude/usage-data/ and ~/.claude/projects/). Trigger whenever the user asks to review, analyze, audit, or critique their own Claude Code usage, workflow, habits, or skill level — including phrases like "analyze my cc usage", "review my cc sessions", "peer review my cc workflow", "deeper than /insights", or any ask for an honest audit of their AI workflow. Also covers portfolio/hiring-manager framings (e.g. "portfolio for Anthropic/OpenAI/xAI"), but ALWAYS ask the user in Step 0 which version to build (self / hr / both) before running — never silently produce an HR report, because that version goes to outsiders and needs explicit privacy setup. The HTML report is laid out ledger-first for SELF (opening band, output/team/leak/trend ledgers, then peer review, 9-dim scoring, try-this-week, case study, claim-indexed evidence). The HR variant is a recruiter version v1: identity card, earned badges (threshold-based, earned-only), allowlist-filtered output ledger, one case study, and a methodology & scope disclosure — no scores, no peer-review memo, no charts.

日本語の概要は準備中です。原文の説明を表示しています。

Build, audit, and modify EMULATORS runtime `.fmt` formatter files and keep them synchronized with C++ `getInfoStructure()` producers and their `.hpp` field documentation. Use when adding, renaming, or removing `InfoStructure` attributes or nested structures; diagnosing missing console fields; reviewing formatter includes, formatter names, placeholders, arrays, nested invocations, or table parameters; or changing namespace-specific `.fmt` files under `projects`.

日本語の概要は準備中です。原文の説明を表示しています。

Control which fields are included or excluded in materializations using depth modes and field overrides. Use when reducing table width, including nested fields, excluding PII, or optimizing performance. Use when user says "exclude fields", "include nested field", "too many columns", "select specific fields", or "field depth".

日本語の概要は準備中です。原文の説明を表示しています。

Backend Node.js Specialist IA — Expert en développement backend Node.js (Express, Fastify, NestJS, Prisma, real-time, WebSockets)

日本語の概要は準備中です。原文の説明を表示しています。

Backend Node.js v2 — Express, NestJS, tRPC, WebSockets, scaling

日本語の概要は準備中です。原文の説明を表示しています。

Execute and test GraphQL depth limit attacks using deeply nested recursive queries to identify denial-of-service vulnerabilities in GraphQL APIs.

日本語の概要は準備中です。原文の説明を表示しています。

Structures biological experiments so inference is valid by construction, covering Fisher's principles (randomization, replication, local control), the experimental-vs-observational unit distinction and pseudoreplication (Hurlbert 1984; Lazic 2018), randomization mechanics (complete, restricted, stratified, rerandomization, run-order), blocking layouts (randomized complete block, Latin square, incomplete block), factorial designs and interactions, and the split-plot/nested error strata hidden inside multi-batch genomics. Use when deciding the experimental unit and what counts as a replicate, planning randomization and run order, choosing a blocked/factorial/split-plot/nested layout, avoiding pseudoreplication in cell-culture or animal studies, or specifying the random-effects structure of the analysis model. For assigning samples to sequencing batches/lanes/plates and batch-effect correction see experimental-design/batch-design; for regulated clinical-trial randomization see clinical-biostatistics.

日本語の概要は準備中です。原文の説明を表示しています。

Validates predictive models on omics and biomedical data with nested cross-validation, group/batch/temporal-aware splits, the full data-leakage taxonomy, probability calibration, decision-curve net benefit, optimism correction, sample-size planning, and TRIPOD+AI reporting. Use when estimating model performance honestly, choosing a CV scheme, detecting leakage, or judging whether reported discrimination means the model is actually useful. For feature selection itself see machine-learning/biomarker-discovery; for confirmatory-trial inference see clinical-biostatistics/trial-reporting.

日本語の概要は準備中です。原文の説明を表示しています。

Runs the MS-DIAL preprocessing workflow (peak picking, MS2Dec spectral deconvolution, alignment, gap-filling) and imports the alignment-result table into R or Python with honest filtering. Use when preprocessing LC-MS DDA/DIA (SWATH) raw data with MS-DIAL, deciding MS-DIAL vs XCMS, configuring the MsdialConsoleApp console run, or parsing an MS-DIAL export into a clean feature matrix. For programmatic R peak detection and the feature-table-as-artifact framing see metabolomics/xcms-preprocessing; for lipid annotation mode see metabolomics/lipidomics; for MSI-level confidence honesty see metabolomics/metabolite-annotation; for drift correction and QC see metabolomics/normalization-qc.

日本語の概要は準備中です。原文の説明を表示しています。

Windows アプリ開発 (DirectX / WinRT メディア) のグラフィックス・メディア API リファレンス。 Direct2D (ID2D1Factory, ID2D1DeviceContext, ID2D1Bitmap1, ID2D1Effect, ID2D1PathGeometry), DirectWrite (IDWriteFactory, IDWriteTextLayout, DWriteCore), Direct3D 11/12 (D3D11CreateDevice, DXGI SwapChain, HLSL, D3D12 PipelineState), Microsoft.UI.Composition (Compositor, Visual, ExpressionAnimation, InteractionTracker, MicaController), カメラ・画面キャプチャ (MediaCapture, MediaFrameReader, GraphicsCaptureSession, Windows Studio Effects)、音声・動画再生 (MediaPlayer, MediaPlaybackSession, AudioGraph, MediaTranscoder, AdaptiveMediaSource)。

Quantifies biodiversity from species abundance/incidence tables using Hill numbers (iNEXT) with coverage-based rarefaction-extrapolation (Chao & Jost 2012), asymptotic richness via Chao1/ACE/jackknife as a lower bound, Baselga turnover/nestedness partition with the Podani alternative as sensitivity check, mandatory Hellinger transformation before ordination (Legendre & Gallagher 2001), Faith PD and SES_MPD/SES_MNTD with explicit null-model choice, and Maire 2015 functional-diversity dimensionality optimization. Use when comparing diversity across sites with unequal sampling effort, picking the right richness estimator for singleton-heavy amplicon data, partitioning beta diversity into turnover vs nestedness, reporting Hill-number effective species counts rather than raw entropies, computing SES_MPD with explicit null-model justification, or deciding whether to apply standard metrics to compositional amplicon data. Not for clinical 16S microbiome diversity (see microbiome/diversity-analysis).

日本語の概要は準備中です。原文の説明を表示しています。

Structures biological experiments so inference is valid by construction, covering Fisher's principles (randomization, replication, local control), the experimental-vs-observational unit distinction and pseudoreplication (Hurlbert 1984; Lazic 2018), randomization mechanics (complete, restricted, stratified, rerandomization, run-order), blocking layouts (randomized complete block, Latin square, incomplete block), factorial designs and interactions, and the split-plot/nested error strata hidden inside multi-batch genomics. Use when deciding the experimental unit and what counts as a replicate, planning randomization and run order, choosing a blocked/factorial/split-plot/nested layout, avoiding pseudoreplication in cell-culture or animal studies, or specifying the random-effects structure of the analysis model. For assigning samples to sequencing batches/lanes/plates and batch-effect correction see experimental-design/batch-design; for regulated clinical-trial randomization see clinical-biostatistics.

日本語の概要は準備中です。原文の説明を表示しています。

Quantifies biodiversity from species abundance/incidence tables using Hill numbers (iNEXT) with coverage-based rarefaction-extrapolation (Chao & Jost 2012), asymptotic richness via Chao1/ACE/jackknife as a lower bound, Baselga turnover/nestedness partition with the Podani alternative as sensitivity check, mandatory Hellinger transformation before ordination (Legendre & Gallagher 2001), Faith PD and SES_MPD/SES_MNTD with explicit null-model choice, and Maire 2015 functional-diversity dimensionality optimization. Use when comparing diversity across sites with unequal sampling effort, picking the right richness estimator for singleton-heavy amplicon data, partitioning beta diversity into turnover vs nestedness, reporting Hill-number effective species counts rather than raw entropies, computing SES_MPD with explicit null-model justification, or deciding whether to apply standard metrics to compositional amplicon data. Not for clinical 16S microbiome diversity (see microbiome/diversity-analysis).

日本語の概要は準備中です。原文の説明を表示しています。

Structures biological experiments so inference is valid by construction, covering Fisher's principles (randomization, replication, local control), the experimental-vs-observational unit distinction and pseudoreplication (Hurlbert 1984; Lazic 2018), randomization mechanics (complete, restricted, stratified, rerandomization, run-order), blocking layouts (randomized complete block, Latin square, incomplete block), factorial designs and interactions, and the split-plot/nested error strata hidden inside multi-batch genomics. Use when deciding the experimental unit and what counts as a replicate, planning randomization and run order, choosing a blocked/factorial/split-plot/nested layout, avoiding pseudoreplication in cell-culture or animal studies, or specifying the random-effects structure of the analysis model. For assigning samples to sequencing batches/lanes/plates and batch-effect correction see experimental-design/batch-design; for regulated clinical-trial randomization see clinical-biostatistics.

日本語の概要は準備中です。原文の説明を表示しています。